How we can help
Capital markets transactions succeed or fail on structure, timing and regulatory judgment. We advise on private and public equity capital raisings, supporting businesses from pre‑IPO and growth funding through to listed market execution. Our work includes IPOs, placements, entitlement offers, share purchase plans, block trades, cornerstone and strategic investments and other capital management transactions, with a particular focus on transactions where timing and key commercial drivers must be carefully managed.
For private companies and investors, we structure capital solutions that align incoming investment with governance settings, exit pathways and listing optionality. For listed issuers, we bring deep knowledge of the ASX Listing Rules and extensive experience engaging with the ASX and ASIC, enabling transactions to proceed efficiently under compressed timeframes.
Across both private and public markets, we work closely with boards, management and advisers to ensure capital decisions support broader corporate strategy – organic growth, enabling acquisitions or repositioning the register.
Experience
-
Fleet Space Technologies
Advised Australia’s leading space company on its $150m Series D fundraising round to assist the company in advancing the discovery of critical minerals essential for a sustainable clean energy future. -
4DMedical
Advised on major capital markets transactions, including its IPO and ASX listing, and subsequent raisings of over $400m via a number of placements, entitlement offers and share purchase plans. -
Aussie Broadband
Advised on several major corporate transactions, including its IPO and ASX listing, and placements and share purchase plans raising over $250m. -
WAM Income Maximiser
Advised on a shareholder-approved equity raising comprising a placement and share purchase plan, raising approximately $148m. -
Silk Logistics
Advised on the $70m IPO and ASX listing, including a $60m secondary sell-down by financial sponsor Tor Asia Credit Master Fund. -
Ryman Healthcare
Advised on the secondary listing of its shares on the ASX, the third-largest ASX listing by market capitalisation in 2025, valued at approximately $2.5bn.